Cosette Peters
Physician Assistant · Marina, CANPI 1265213375
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Lundbeck LLC at 25.6% of the total. Reporting peaked in 2024 at $418 and has fallen 82.1% since, to $75 in 2025.
Across 26 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$142
- Teva Pharmaceuticals USA, Inc.$89
- Pfizer$44
- Axsome Therapeutics, Inc.$43
- Takeda Pharmaceuticals U.S.A., Inc.$37
- Exact Sciences$32
- plus $167 from 7 others
What the payments were for
- Food & beverage$53497%
- Entertainment$183%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 6 | $142 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| Pfizer | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Exact Sciences | 2 | $32 |
| Corium, LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Indivior Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $19 |
| Optos, Inc. | 1 | $18 |
How this compares
$552 in reported general payments places this provider in the 60th percentile of 10,423 physician assistant providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 23 | $232 |
| Losartan Potassium | 20 | $220 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $114 |
| Lisinopril | 20 | $56 |
| Metoprolol Tartrate | 11 | $33 |
| Metformin Hcl | 12 | $33 |
| Hydrochlorothiazide | 16 | $20 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Marina
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
- Asma HussainiThousand Oaks$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.